Literature DB >> 30427

Delusional unipolar depression: description and drug response.

J C Nelson, M B Bowers.   

Abstract

This retrospective study describes the response of 13 delusional unipolar depressives to combination antipsychotic-tricyclic antidepressant drug therapy. The Research Diagnostic Criteria were used by two independent raters to verify the presence of a delusional, primary, unipolar, major depressive disorder. Thirteen patients met the criteria and received combined antipsychotic-antidepressant pharmacotherapy. Twelve of the 13 responded. This contrasts sharply with the low response rate described for delusional depressives when treated with tricyclic antidepressants alone. Descriptive characteristics of the delusional depressives were compared with those of a group of nondelusional unipolar depressives. Delusional depressives had histories of a greater number of prior depressive episodes and more of the delusional depressives demonstrated a psychomotor disturbance.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 30427     DOI: 10.1001/archpsyc.1978.01770350047004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  8 in total

Review 1.  Diagnosis and treatment of psychotic symptoms in elderly patients.

Authors:  J T Lake; A H Rahman; G T Grossberg
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 2.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

Review 3.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Depression in older persons: diagnosis and management.

Authors:  R Barnes; R C Veith; M A Raskind
Journal:  West J Med       Date:  1981-12

5.  A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).

Authors:  Barnett S Meyers; Alastair J Flint; Anthony J Rothschild; Benoit H Mulsant; Ellen M Whyte; Catherine Peasley-Miklus; Eros Papademetriou; Andrew C Leon; Moonseong Heo
Journal:  Arch Gen Psychiatry       Date:  2009-08

Review 6.  Current issues in the classification of psychotic major depression.

Authors:  Jennifer Keller; Alan F Schatzberg; Mario Maj
Journal:  Schizophr Bull       Date:  2007-06-04       Impact factor: 9.306

7.  Structural brain networks in remitted psychotic depression.

Authors:  Nicholas H Neufeld; Antonia N Kaczkurkin; Aristeidis Sotiras; Benoit H Mulsant; Erin W Dickie; Alastair J Flint; Barnett S Meyers; George S Alexopoulos; Anthony J Rothschild; Ellen M Whyte; Linda Mah; Jay Nierenberg; Matthew J Hoptman; Christos Davatzikos; Theodore D Satterthwaite; Aristotle N Voineskos
Journal:  Neuropsychopharmacology       Date:  2020-02-28       Impact factor: 8.294

8.  Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment.

Authors:  Reiji Yoshimura; Koshiro Tsuji; Nobuhisa Ueda; Jun Nakamura
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.